BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

835 related articles for article (PubMed ID: 29175065)

  • 1. Effect of the initiation of progesterone supplementation in in vitro fertilization-embryo transfer outcomes: a prospective randomized controlled trial.
    Gao J; Gu F; Miao BY; Chen MH; Zhou CQ; Xu YW
    Fertil Steril; 2018 Jan; 109(1):97-103. PubMed ID: 29175065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol supplementation during the luteal phase of IVF-ICSI patients: a randomized, controlled trial.
    Serna J; Cholquevilque JL; Cela V; Martínez-Salazar J; Requena A; Garcia-Velasco JA
    Fertil Steril; 2008 Dec; 90(6):2190-5. PubMed ID: 18191847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitrified blastocyst transfer cycles with the use of only vaginal progesterone replacement with Endometrin have inferior ongoing pregnancy rates: results from the planned interim analysis of a three-arm randomized controlled noninferiority trial.
    Devine K; Richter KS; Widra EA; McKeeby JL
    Fertil Steril; 2018 Feb; 109(2):266-275. PubMed ID: 29338855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does the addition of growth hormone to the in vitro fertilization/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial.
    Bassiouny YA; Dakhly DMR; Bayoumi YA; Hashish NM
    Fertil Steril; 2016 Mar; 105(3):697-702. PubMed ID: 26690008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Utrogestan during controlled ovarian hyperstimulation in normally ovulating women undergoing in vitro fertilization or intracytoplasmic sperm injection treatments in combination with a "freeze all" strategy: a randomized controlled dose-finding study of 100 mg versus 200 mg.
    Zhu X; Ye H; Fu Y
    Fertil Steril; 2017 Feb; 107(2):379-386.e4. PubMed ID: 27865446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramuscular progesterone optimizes live birth from programmed frozen embryo transfer: a randomized clinical trial.
    Devine K; Richter KS; Jahandideh S; Widra EA; McKeeby JL
    Fertil Steril; 2021 Sep; 116(3):633-643. PubMed ID: 33992421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of luteal phase vaginal estradiol supplementation on the success of in vitro fertilization treatment: a prospective randomized study.
    Engmann L; DiLuigi A; Schmidt D; Benadiva C; Maier D; Nulsen J
    Fertil Steril; 2008 Mar; 89(3):554-61. PubMed ID: 17678651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of luteal serum progesterone levels on live birth rates-a prospective study of 602 IVF/ICSI cycles.
    Thomsen LH; Kesmodel US; Erb K; Bungum L; Pedersen D; Hauge B; Elbæk HO; Povlsen BB; Andersen CY; Humaidan P
    Hum Reprod; 2018 Aug; 33(8):1506-1516. PubMed ID: 29955789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gonadotropin-releasing hormone analogue as sole luteal support in antagonist-based assisted reproductive technology cycles.
    Bar Hava I; Blueshtein M; Ganer Herman H; Omer Y; Ben David G
    Fertil Steril; 2017 Jan; 107(1):130-135.e1. PubMed ID: 28228316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N; Chen Q; Hong Q; Cai R; Gao H; Wang Y; Sun L; Zhang S; Guo H; Fu Y; Ai A; Tian H; Lyu Q; Daya S; Kuang Y
    Fertil Steril; 2016 Aug; 106(2):334-341.e1. PubMed ID: 27114329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The addition of gonadotrophin releasing hormone agonist to routine luteal phase support in intracytoplasmic sperm injection and embryo transfer cycles: a randomized clinical trial.
    Yıldız GA; Şükür YE; Ateş C; Aytaç R
    Eur J Obstet Gynecol Reprod Biol; 2014 Nov; 182():66-70. PubMed ID: 25238659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does the Time of Starting Progesterone Luteal Support Affect Embryo Transfer in Long Agonist Protocol Downregulated ICSI Cycles? A Randomized Controlled Trial.
    Ghanem ME; Bedairy MH; Shaaban A; Albahlol IA
    Reprod Sci; 2021 Mar; 28(3):897-903. PubMed ID: 32909190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 450 IU versus 600 IU gonadotropin for controlled ovarian stimulation in poor responders: a randomized controlled trial.
    Lefebvre J; Antaki R; Kadoch IJ; Dean NL; Sylvestre C; Bissonnette F; Benoit J; Ménard S; Lapensée L
    Fertil Steril; 2015 Dec; 104(6):1419-25. PubMed ID: 26361207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased odds of live birth in fresh in vitro fertilization cycles with shorter ovarian stimulation.
    Pereira N; Friedman C; Hutchinson AP; Lekovich JP; Elias RT; Rosenwaks Z
    Fertil Steril; 2017 Jan; 107(1):104-109.e2. PubMed ID: 27793370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryopreserved oocyte versus fresh oocyte assisted reproductive technology cycles, United States, 2013.
    Crawford S; Boulet SL; Kawwass JF; Jamieson DJ; Kissin DM
    Fertil Steril; 2017 Jan; 107(1):110-118. PubMed ID: 27842997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial.
    Boostanfar R; Gates D; Guan Y; Gordon K; McCrary Sisk C; Stegmann BJ
    Fertil Steril; 2016 Aug; 106(2):300-305.e5. PubMed ID: 27090863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of luteal phase support with vaginal progesterone on the clinical pregnancy rate in intrauterine insemination cycles stimulated with gonadotropins: a randomized multicenter study.
    Peeraer K; D'Hooghe T; Laurent P; Pelckmans S; Delvigne A; Laenen A; Welkenhuysen M; Wyns C; De Neubourg D
    Fertil Steril; 2016 Nov; 106(6):1490-1495. PubMed ID: 27565253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the time interval between hysteroscopic polypectomy and start of in vitro fertilization affect outcomes?
    Pereira N; Amrane S; Estes JL; Lekovich JP; Elias RT; Chung PH; Rosenwaks Z
    Fertil Steril; 2016 Feb; 105(2):539-44.e1. PubMed ID: 26604066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual trigger for final oocyte maturation improves the oocyte retrieval rate of suboptimal responders to gonadotropin-releasing hormone agonist.
    Lu X; Hong Q; Sun L; Chen Q; Fu Y; Ai A; Lyu Q; Kuang Y
    Fertil Steril; 2016 Nov; 106(6):1356-1362. PubMed ID: 27490046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.